RECOMBINANT PROTEIN ASP-PALLIDIPIN, METHOD OF ITS PRODUCTION AND PURIFICATION, VECTOR, STRAIN, PHARMACEUTICAL COMPOSITION Russian patent published in 2002 - IPC

Abstract RU 2186110 C2

FIELD: biotechnology, medicine, pharmacy. SUBSTANCE: recombinant protein Asp-pallidipin is bound by peptide bond with Asp by N-end of pallidipin. Recombinant protein is able to inhibit collagen- induced aggregation of mammalian platelets. Protein is prepared by culturing Escherichia coli strain transformed with vector comprising DNA that encodes Asp-pallidipin. Protein is purified by chromatography methods. Invention ensures to obtain a medicinal agent used for treatment of atherosclerotic or thrombotic diseases and cancer with metastatic tumor cells. Invention can be used for preparing an inhibitor of collagen- induced aggregation of platelets in mammals. EFFECT: improved method of production, valuable medicinal properties. 11 cl, 3tbl, 6 ex

Similar patents RU2186110C2

Title Year Author Number
PROTEIN INHIBITING COLLAGEN-CAUSED AGGREGATION OF MAMMALIAN PLATELETS, RECOMBINANT PROTEIN INHIBITING COLLAGEN-CAUSED AGGREGATION OF PLATELETS, DNA FRAGMENT ENCODING RECOMBINANT PROTEIN, EXPRESSION VECTOR (VARIANTS), STRAIN OF CULTURED MAMMALIAN CELLS BHK - PRODUCER OF RECOMBINANT PROTEIN (VARIANTS), METHOD OF PREPARING RECOMBINANT PROTEIN, PHARMACEUTICAL COMPOSITION 1992
  • Kristiane Neske-Jungblut
  • Bernkhard Khehndler
  • Jern Krehttsshmar
  • Vol'F-Diter Shlojning
  • Alekhandro Alagon
  • Lurival' Domingos Possani
  • Delia Anatolia Kevas-Agirre
RU2128705C1
NATURAL AND RECOMBINANT THROMBIN INHIBITORS, THEIR PREPARING AND USE 1993
  • Neske-Jungblut Kristiane
  • Shlojning Vol'F-Diter
  • Alagon Alekhandro
  • Possani Lourival'
  • Kuehvas-Agirre Delia
  • Donner Peter
  • Khehndler Bernard
  • Khekhler Ul'Rike
RU2183214C2
HUMAN LIPOCALIN 2 MUTEINS (Lcn2, hNGAL) WITH TARGETED AFFINITY 2019
  • Skerra Arne
  • Gebauer Michaela
  • Hinz Dominik
  • Rauth Sabine
  • Matschiner Gabriele
  • Huelsmeyer Martin
RU2804336C2
MUTEINS OF HUMAN LIPOCALIN 2 (LCN2, HNGAL) WITH AFFINITY TO CERTAIN TARGET 2010
  • Skerra Arne
  • Gebauehr Mikhaehla
  • Khints Dominik
  • Raut Zabine
  • Machiner Gabriehle
  • Khjul'Smejer Martin
RU2564125C2
HUMAN LIPOLOCAL 2 MALLETES (LCN2, HNGAL) WITH AFFINITY FOR SPECIFIC TARGET 2010
  • Skerra Arne
  • Gebauer Mikhaela
  • Khints Dominik
  • Raut Zabine
  • Machiner Gabriele
  • Khyulsmejer Martin
RU2707126C2
PROTEINS BINDING TO HEPCIDIN 2011
  • Trentmann Stefan
  • Matshiner Gabriele
  • Skerra Arne
  • Kholbaum Andreas
  • Khyulsmejer Martin
  • Gille Khendrik
  • Kristian Khans-Yurgen
  • Jensen Kristian
  • Bel Ajba Rachida Sikham
RU2625011C2
TEAR LIPOCALIN MUTEINS, BINDING ALPHA IL-4 R 2011
  • Khol'Baum Andreas
  • Bere Aleksandra
  • Machiner Gabriehle
  • Trentmann Stefan
  • Kirkhled Klaus
  • Khristian Khans-Jurgen
RU2569745C2
NEW THROMBOMODULINE FUSION PROTEINS PROVIDING DIRECTIONAL TRANSFER TO TISSUE FACTOR AS ANTICOAGULANTS 2003
  • Lajt Dejvid
  • Maklin Kerk
RU2320366C2
NEW TISSUE FACTOR ANTIBODIES AS ANTICOAGULANTS 2003
  • Lajt Dejvid
  • Maklin Kerk
RU2345789C2
MUTEINS OF TEAR LIPOCALIN, POSSESSING AFFINITY TO HUMAN C-MET RECEPTOR TYROSINE KINASE AND METHODS OF OBTAINING THEM 2009
  • Matshiner Gabriehle
  • Khol'Baum Andreas
  • Khuehl'Smejer Martin
  • Trentmann Stefan
RU2515063C9

RU 2 186 110 C2

Authors

Noeske-Jungblut Kristiane

Beker Andreas

Khendler Bernard

Dates

2002-07-27Published

1995-09-11Filed